Intranasal and intramuscular H5-Matrix-M nanoparticle vaccines protects against highly pathogenic H5N1 influenza virus in mice
npj Vaccines·
- DOI
- 10.1038/s41541-026-01523-8
- PMID
- 42431930
- PMCID
- —
- OpenAlex
- W7167935461
- Study type
- Journal article
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The data indicate that this adjuvanted nanoparticle approach may circumvent interference from existing seasonal influenza antibodies, highlighting its potential utility in pandemic response strategies.
Structured evidence summary
Research question
The investigation evaluates whether a Matrix-M-adjuvanted nanoparticle vaccine can generate protective immune responses against an emerging H5N1 strain when delivered via nasal or injection routes.
Study design
A controlled animal experiment utilizing two mouse cohorts, one unexposed and one previously administered a seasonal influenza formulation, followed by targeted viral challenge.
Population and setting
Laboratory mice subjected to either baseline conditions or prior seasonal influenza immunization before receiving the experimental nanoparticle construct.
Main findings
Both delivery methods triggered substantial antibody production and prevented mortality following lethal exposure. Previously immunized animals required only a single booster dose to achieve comparable defense, while nasal application resulted in lower viral detection within the upper respiratory tract compared to injections.
Public-health relevance
The data indicate that this adjuvanted nanoparticle approach may circumvent interference from existing seasonal influenza antibodies, highlighting its potential utility in pandemic response strategies.
Important limitations
Findings are restricted to murine models and do not account for human physiological differences, extended durability of protection, or adverse event profiling.
GIDS interpretation
This record documents early-stage experimental work on a specific adjuvanted platform targeting an evolving avian influenza lineage, offering contextual background for monitoring vaccine innovation trajectories rather than active epidemiological tracking.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.